Spoon-feed Source and boost your yields farmprogress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from farmprogress.com Daily Mail and Mail on Sunday newspapers.
RESEARCH TRIANGLE PARK –Vestaron, a company developing biopesticides for targeted, safe, and efficient crop protection, has raised $18 million in an oversubscribed B-1 financing,
Northpond Ventures led the round. Northpond and additional new investor, Cavallo Ventures, the venture arm of Wilbur-Ellis, join continuing investors Novo Holdings, Syngenta Ventures, CGC Ventures, and Anterra Capital.
The company moved its corporate headquarters to Research Triangle Park from Kalamazoo, Michigan, in 2019. It previously raised a $40 million B round from an impressive investor syndicate.
Peptides (small proteins) have the same proven modes of action (a nerve and muscular attack) and the same efficacy as traditional synthetics but with the safety and environmental friendliness of biologics.
Share this article
Share this article
RESEARCH TRIANGLE PARK, N.C., Feb. 16, 2021 /PRNewswire/ Vestaron, a company dedicated to improving the safety, efficacy and sustainability of crop protection through its development of peptide-based biopesticides, announces $18 million in Series B-1 financing, led by Northpond Ventures. Northpond and additional new investor, Cavallo Ventures, the venture arm of Wilbur-Ellis, join continuing investors Novo Holdings, Syngenta Ventures, CGC Ventures and Anterra Capital in this round. Adam Wieschhaus, Director at Northpond Ventures, will join the Vestaron Board of Directors.
With its proprietary platform for the optimization, production and delivery of peptide-based biopesticides, Vestaron is leading the development of a novel class of crop protection products – peptides (small proteins). These peptides have the proven modes of action and thus the same efficacy as traditional synthetics with the safety and environmental friendliness of biolog
RESEARCH TRIANGLE PARK – Agtech startup AgBiome, which already has raised $100 million from several high-profile investors such as the Bill and Melinda Gates Foundation, has additional equity and a new chair.
Dr. Marijn Dekkers, former CEO at both Bayer AG and Thermo Fisher Scientific, took over as AgBiome chair as of Jan. 1, the company announced Tuesday.
Also, Novalis LifeSciences has made an investment in AgBiome. Dekkers is the founder and chair of the investment and advisory firm.
A spokesperson for AgBiome confirmed the Novalis investment after an inquiry from WRAL TechWire.
“With decades of exceptional leadership experience as a chief executive and in chairing boards of successful companies, alongside deep institutional knowledge across AgBiome’s business and strategic prospects, Dr. Dekkers is the ideal next Chairman of the Board to lead AgBiome to the next chapter of success,” said Eric Ward, co-CEO at AgBiome along with Scott Uknes.
Water conservation thrives on technology and innovation agweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from agweb.com Daily Mail and Mail on Sunday newspapers.